Endometrial cancer is the most common women’s reproductive cancers, and ovarian cancer is the most deadly.
In Australia in 2018, over 6000 women were diagnosed with a gynaecological cancer. In the same year, over 1700 women died from the disease. This accounts for 9.4% of female deaths from cancer in this year.
HMRI researchers are determined to find earlier diagnosis, treatments – and, ultimately, a cure for these cancers.
Join us at HMRI on Wednesday April 3 from 5.30pm to hear from cancer research leaders at a Public Seminar on women’s gynaecological cancers.
Associate Professor Nikola Bowden is the DNA Repair Group Leader and leads a team of research staff, clinicians and students who work together to use traditional chemotherapy in new ways to treat ovarian cancer and melanoma. Nikola is the recipient of the Vanessa McGuigan HMRI Research Fellowship in Ovarian Cancer supported by the McGuigan Family.
Associate Professor Pradeep Tanwar investigates what goes wrong with the female reproductive organs in pathologies, specifically endometriosis and gynaecological cancers, and how we can fix it. He aims to develop prevention strategies for reproductive tract cancers and diseases, as well targeted therapies that lead to improved prognosis and new chemotherapy dose-reduction strategies for improved quality of life for women suffering endometriosis, ovarian uterine and other gynecological cancers.
Dr Rachel O'Sullivan is a clinician at the John Hunter Hospital. Rachel will speak about how recent research has impacted on and changed clinical practice in Gynaecological cancers. Rachel works closely with researchers like Pradeep and Nikola, and will share updates on some of the clinical trials her unit is involved in.
This event is being recorded and will be live streamed on Facebook.
The recorded material may also be edited and used in other forms including social media, radio, television, newspaper, magazine, internet or other means.
By attending and participating in this event you authorise your likeness and voice, and any activity undertaken in relation to this event to be used by Hunter Medical Research Institute, University of Newcastle and Hunter New England Health and acknowledge that you assign all rights, title and interest including copyright to HMRI in perpetuity.